malondialdehyde has been researched along with Peripheral Arterial Disease in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (90.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, H; Goto, T; Ito, T; Kawada, Y; Kikuchi, S; Kitada, S; Mizoguchi, T; Mori, K; Nakasuka, K; Seo, Y; Yamamoto, J; Yokoi, M | 1 |
| Akao, H; Kajinami, K; Kawai, Y; Kitayama, M; Oda, M; Saito, R; Sato-Ishida, R; Takamura, TA; Tsuchiya, T; Watanabe, M | 1 |
| Ballard, KD; Berry, CW; Bruno, RS; Dey, P; Duguid, RM; Timmerman, KL; Ward, RM | 1 |
| Kasprzak, M; Majewski, W; Pioruńska-Stolzmann, M; Strzyżewski, KW; Strzyżewski, W | 1 |
| Ahmadi, Y; Badalzadeh, R; Faghfoori, Z; Ghavimi, H; Jabbarpour, M; Karami, H; Majidinia, M; Samadi, N; Shafiei-Irannejad, V; Yousefi, B | 1 |
| Brasileiro-Santos, M; Correia, M; Forjaz, CL; Lima, A; Miranda, A; Ritti-Dias, R; Santos, A; Silva, A; Sobral Filho, D | 1 |
| Amrein, K; Binder, J; Cvirn, G; Ferstl, U; Froehlich, H; Hallström, S; Hörl, G; Jürgens, G; Koidl, C; Ledinski, G; Scharnagl, H; Stojakovic, T; Tafeit, E; Trauner, M | 1 |
| Brasileiro-Santos, MS; Correia, MA; Farah, BQ; Forjaz, CLM; Lima, AHRA; Ritti-Dias, RM; Santos, AC; Silva, AS; Soares, AHG | 1 |
| Akgün, OO; Altan, H; Arslan, C; Aydemir, B; Besirli, K; Bozkurt, AK; Güzel, S; Kiziler, AR | 1 |
| Geshi, T; Lee, JD; Mitsuke, Y; Morishita, T; Nakano, A; Ueda, T; Uzui, H | 1 |
3 trial(s) available for malondialdehyde and Peripheral Arterial Disease
| Article | Year |
|---|---|
Effects of prior aerobic exercise on sitting-induced vascular dysfunction in healthy men.
Topics: Arginine; Blood Glucose; Endothelin-1; Endothelium, Vascular; Exercise; Exercise Therapy; Femoral Artery; Humans; Immobilization; Male; Malondialdehyde; Nitric Oxide; Peripheral Arterial Disease; Posture; Regional Blood Flow; Vasodilation; Young Adult | 2017 |
A session of resistance exercise increases vasodilation in intermittent claudication patients.
Topics: Aged; Endothelium, Vascular; Female; Humans; Hyperemia; Hypertension; Intermittent Claudication; Leg; Lipid Peroxidation; Male; Malondialdehyde; Microvessels; Middle Aged; Nitric Oxide; Nitrites; Peripheral Arterial Disease; Regional Blood Flow; Resistance Training; Vasodilation | 2015 |
Acute effects of walking and combined exercise on oxidative stress and vascular function in peripheral artery disease.
Topics: Aged; Ankle Brachial Index; Biomarkers; Blood Pressure; Female; Hemodynamics; Humans; Hyperemia; Intermittent Claudication; Lower Extremity; Male; Malondialdehyde; Middle Aged; Nitrites; Oxidative Stress; Peripheral Arterial Disease; Resistance Training; Risk Factors; Time Factors; Treatment Outcome; Vascular Resistance; Walking Speed | 2018 |
7 other study(ies) available for malondialdehyde and Peripheral Arterial Disease
| Article | Year |
|---|---|
Malondialdehyde-Modified Low-Density Lipoprotein as a Predictor of Major Adverse Limb Events after Endovascular Therapy in Patients with Lower Extremity Arterial Disease.
Topics: Cholesterol, LDL; Endovascular Procedures; Humans; Ischemia; Limb Salvage; Lower Extremity; Malondialdehyde; Peripheral Arterial Disease; Retrospective Studies; Risk Factors; Treatment Outcome | 2023 |
Circulating malondialdehyde-modified low-density lipoprotein (MDA-LDL) as a novel predictor of clinical outcome after endovascular therapy in patients with peripheral artery disease (PAD).
Topics: Aged; Biomarkers; C-Reactive Protein; Chi-Square Distribution; Endovascular Procedures; Female; Fibrin Fibrinogen Degradation Products; Humans; Interleukin-6; Kaplan-Meier Estimate; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Multivariate Analysis; Peripheral Arterial Disease; Proportional Hazards Models; Risk Factors; Time Factors; Treatment Outcome | 2017 |
Effect of surgical treatment on lipid peroxidation parameters and antioxidant status in the serum of patients with peripheral arterial disease.
Topics: Aged; Anticholesteremic Agents; Antioxidants; Ceruloplasmin; Humans; Lipid Peroxidation; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Peripheral Arterial Disease; Postoperative Period; Simvastatin | 2013 |
The effects of Ramadan fasting on endothelial function in patients with cardiovascular diseases.
Topics: Adult; Arginine; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease; Endothelium, Vascular; Fasting; Humans; Islam; Male; Malondialdehyde; Middle Aged; Nitric Oxide; Peripheral Arterial Disease; Vascular Endothelial Growth Factor A | 2014 |
Simvastatin Efficiently Lowers Small LDL-IgG Immune Complex Levels: A Therapeutic Quality beyond the Lipid-Lowering Effect.
Topics: Adult; Aged; Aged, 80 and over; Antigen-Antibody Complex; Apolipoproteins B; Cholesterol, LDL; Coronary Artery Disease; Coronary Restenosis; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin G; Male; Malondialdehyde; Middle Aged; Peripheral Arterial Disease; Simvastatin | 2016 |
Trace elements and toxic heavy metals play a role in Buerger disease and atherosclerotic peripheral arterial occlusive disease.
Topics: Adult; Analysis of Variance; Arterial Occlusive Diseases; Biomarkers; Cadmium; Copper; Glutathione; Glutathione Peroxidase; Humans; Iron; Lead; Malondialdehyde; Metals, Heavy; Middle Aged; Oxidative Stress; Peripheral Arterial Disease; Risk Assessment; Risk Factors; Selenium; Thromboangiitis Obliterans; Trace Elements; Turkey; Zinc | 2010 |
Number of endothelial progenitor cells in peripheral artery disease as a marker of severity and association with pentraxin-3, malondialdehyde-modified low-density lipoprotein and membrane type-1 matrix metalloproteinase.
Topics: Aged; Antigens, CD34; Biomarkers; C-Reactive Protein; Case-Control Studies; Cells, Cultured; Endothelial Cells; Female; Flow Cytometry; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Matrix Metalloproteinase 14; Peripheral Arterial Disease; Serum Amyloid P-Component; Stem Cells | 2012 |